Clinical trial
Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
NCT02541708 is registered in ClinicalTrials.gov with Ifakara Health Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
- Lead sponsor
- Ifakara Health Institute
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 30, 2015
- Completion date
- April 30, 2018
- Enrollment
- 230 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
iron-deficiency anemia